Catalyst
Slingshot members are tracking this event:
Evoke Phase 3 Results for EVK-001 in Acute and Recurrent Diabetic Gastroparesis in Women Expected Early Q3
Do you think this event is important to the companies below? How will it affect their stock price?
Related Companies | Importance
|
Impact on Stocks
|
||||
---|---|---|---|---|---|---|
EVOK |
|
|
Additional Information
Slingshot Insights Explained
Catalyst Date
Occurred on:
Jul 18, 2016
Occurred Source:
http://investor.evokepharma.com/releasedetail.cfm?ReleaseID=979872
Related Projects
Related Keywords
Diabetic Gastroparesis, Women's Health, Phase 3 Results, Evk-001